Asklepios BioPharmaceutical (AskBio)
Research Triangle, NC · San Sebastian, ES
Hybrid — also manufactures internal programs
10 confirmed programs
· 4 sponsors
· Last scored 2026-10-29
61.8
Signal Score
○ FDA Inspections
✓ Clinical Trials (10)
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Asklepios BioPharmaceutical (AskBio)
- Signal Score
- 61.8/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Research Triangle, NC · San Sebastian, ES
- Modalities
- AAV
- Active Programs
- 10 confirmed from ClinicalTrials.gov across 4 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Asklepios BioPharmaceutical (AskBio)
Hybrid developer + CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
60.0
10 active programs across 4 sponsors
Modalities: AAV
5 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
10 active programs across 4 sponsors · Modalities: AAV · 5 programs in advanced phases (Phase 2/3)
Programs
10
Sponsors4
ModalitiesAAV
10 active programs across 4 sponsors
Modalities: AAV
5 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
NCT05230459
A Study to Evaluate the Safety of AB-1003 (Previously...
PHASE1/PHASE2
Active Not Recruiting
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Financial Stability
68.0
Parent company: Bayer
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Bayer
Financial assessment: 68.0/100
Capacity
58.0
2 manufacturing sites
Sites: Research Triangle, NC, San Sebastian, ES
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
2 manufacturing sites
Clinical Activity 10 studies
NCT07566429
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's...
PHASE2
Not Yet Recruiting
NCT07282847
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene...
PHASE1/PHASE2
Recruiting
NCT07081841
AB-1005 Long-Term Follow-up Study
NA
Enrolling By Invitation
NCT06285643
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
PHASE2
Recruiting
NCT05598333
Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With...
PHASE2
Active Not Recruiting
NCT05230459
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects...
PHASE1/PHASE2
Active Not Recruiting
NCT05699460
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
NA
Completed
NCT04167540
GDNF Gene Therapy for Parkinson's Disease
PHASE1
Active Not Recruiting
NCT03533673
AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
PHASE1
Completed
NCT00428935
Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy
PHASE1
Completed
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business (4 postings on Nov 20, 2026), and we can't yet tell which of those roles belong to it. Why: the careers board covers the gene-therapy biotech, not its manufacturing arm. We'd rather show no number than one that isn't really this company's.
Source:
askbio.wd12.myworkdayjobs.com
· Checked Nov 20, 2026
Frequently Asked Questions About Asklepios BioPharmaceutical (AskBio)
How many clinical programs is Asklepios BioPharmaceutical (AskBio) linked to?
Asklepios BioPharmaceutical (AskBio) is associated with 10 clinical trials in CDMO Signal's ClinicalTrials.gov-sourced data.
What is Asklepios BioPharmaceutical (AskBio)'s CDMO Signal Score?
Asklepios BioPharmaceutical (AskBio) has a Signal Score of 62/100, based on quality, operations, financial stability, and capacity data.
Evaluating Asklepios BioPharmaceutical (AskBio) for a manufacturing program?
Use the free AI matchmaker to compare Asklepios BioPharmaceutical (AskBio) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Takeda
Boston, MA · Zurich, CH
Signal Score: 83.4
AAV, Cell Therapy
Compare Asklepios BioPharmaceutical (AskBio) with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.